In one paragraphArticle in Immunotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Leila HaghaniInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, H-118, New York, NY 10065, USA.ORCID 0000-0001-7156-4004 Chenyang ZhanInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, H-118, New York, NY 10065, USA.
Hooman YarmohammadiInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, H-118, New York, NY 10065, USA.ORCID 0000-0002-3127-9222 Etay ZivInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, H-118, New York, NY 10065, USA.
Vlasios S SotirchosInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, H-118, New York, NY 10065, USA.ORCID 0000-0001-7278-1369 Debkumar SarkarInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, H-118, New York, NY 10065, USA.ORCID 0000-0002-4647-8339 Alexander N ShoushtariDepartment of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065,USA.ORCID 0000-0002-8065-4412 Joseph P ErinjeriInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, H-118, New York, NY 10065, USA.ORCID 0000-0003-1876-727X Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MNCI NIH HHS P30 CA008748NIH/NCI Cancer Center Support Grant P30 (CA008748)
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Embolization, TherapeuticImmunotherapyMelanomaAdultAgedCohort StudiesFemaleHumansImmune Checkpoint InhibitorsLiver NeoplasmsMaleMiddle AgedNeoplasm MetastasisRetrospective StudiesSkin NeoplasmsImmune Checkpoint InhibitorsCheckpoint inhibitorimmunotherapyinterventional radiologymetastatic melanomatimingtransarterial embolizationtreatment sequence
Identifiers
PMID39225651
PMCPMC11485943
What OpenQuestion holds
Textmetadata
Read underepoch 390